S0859, an N-cyanosulphonamide inhibitor of sodium-bicarbonate cotransport in the heart

101Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and purpose: Intracellular pH (pHi) in heart is regulated by sarcolemmal H+-equivalent transporters such as Na +-H+ exchange (NHE) and Na+-HCO3- cotransport (NBC). Inhibition of NBC influences pHi and can be cardioprotective in animal models of post-ischaemic reperfusion. Apart from a rabbit polyclonal NBC-antibody, a selective NBC inhibitor compound has not been studied. Compound S0859 (C29H24ClN 3O3S) is a putative NBC inhibitor. Here, we provide the drug's chemical structure, test its potency and selectivity in ventricular cells and assess its suitability for experiments on cardiac contraction. Experimental approach: pHi recovery from intracellular acidosis was monitored using pH-epifluorescence (SNARF-fluorophore) in guinea pig, rat and rabbit isolated ventricular myocytes. Electrically evoked cell shortening (contraction) was measured optically. With CO2/HCO3--buffered superfusates containing 30 μM cariporide (to inhibit NHE), pHi recovery is mediated by NBC. Key results: S0859, an N-cyanosulphonamide compound, reversibly inhibited NBC-mediated pHi recovery (K i=1.7 μM, full inhibition at ∼30 μM). In HEPES-buffered superfusates, NHE-mediated pHi recovery was unaffected by 30 μM S0859. With CO2/HCO3- buffer, pHi recovery from intracellular alkalosis (mediated by Cl -/HCO3- and Cl-/OH- exchange) was also unaffected. Selective NBC-inhibition was not due to action on carbonic anhydrase (CA) enzymes, as 100 μM acetazolamide (a membrane-permeant CA-inhibitor) had no significant effect on NBC activity. pHi recovery from acidosis was associated with increased contractile-amplitude. The time course of recovery of pHi and contraction was slowed by S0859, confirming that NBC is a significant controller of contractility during acidosis. Conclusions and implications: Compound S0859 is a selective, high-affinity generic NBC inhibitor, potentially important for probing the transporter's functional role in heart and other tissues. © 2008 Nature Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Ch’en, F. F. T., Villafuerte, F. C., Swietach, P., Cobden, P. M., & Vaughan-Jones, R. D. (2008). S0859, an N-cyanosulphonamide inhibitor of sodium-bicarbonate cotransport in the heart. British Journal of Pharmacology, 153(5), 972–982. https://doi.org/10.1038/sj.bjp.0707667

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free